Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is ...

Johnson & Johnson (NYSE:JNJ) has had a rough three months with its share price down 11%. However, stock prices ...

Johnson & Johnson (JNJ) stock saw a modest uptick, ending the day at $148.15 which represents a slight increase of $1.12 or 0.76% from the prior close of $147.03. The stock opened at $147.56 and ...

Discover why JNJ's long-term buy rating is supported by its blue-chip status, profitability, and diverse revenue lines, despite recent challenges.

Cautiously Positive Outlook as Election Season Heats Up The stock market was in solid shape ... are not sufficient to fully offset high prices and high interest rates, which are constraining ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a ...

We recently published a list of the 10 Best Soaps and Cleaning Materials Stocks to Invest In. In this article, we are going ...

JOHNSON & JOHNSON (JNJ) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 80% based on the firm’s underlying fundamentals and the stock’s ...